Skip to main content

Advertisement

Table 1 Characteristics of the patients

From: MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia

  Training set Test set
  Not Responder group Complete Responder group Not Responder group Complete Responder group
  n = 8 n = 9 n = 5 n = 7
Male, n(%) 7 (87.5%) 6 (66.6%) 4 (80%) 2 (28.6%)
Female, n(%) 1 (12.5%) 3 (33.3%) 1 (20%) 5 (71.4%)
Median age at diagnosis, years(range) 67,5 (35-80) 66 (40-85) 68 (61-76) 60 (37-78)
11qdel, n(%) 0 (0%) 2 (22.2%) 0 (0%) 0 (0%)
17pdel, n(%) 2 (25%) 1 (11.1%) 3 (60%) 0 (0%)
Previous lines of therapy, n (%) (clorambucil) 8 (100%) 5 (55.5%) 4 (80%) 3 (42.9%)
Rai Stage, n (%)     
0-I 7 (87.5%) 9 (100%) 2 (40%) 4 (57.1%)
II-IV 1 (12.5%) 0 (0%) 3 (60%) 3 (42.9%)
Time to Treatment (months) 35.6 (0-75) 17.0 (0-56) 7.7 (0-20) 32.2 (10-75)